Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
US6083990A · kind A · utility
1Cited by
7References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 1997 |
| Grant date | Jul 4, 2000 |
| Priority date | — |
| Expiry date | Apr 2, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses the use of permanently charged steroid agonists or antagonists as potent anti-angiogenic compositions comprising as an active ingredient a compound of the general formulae I, II or III: ##STR1## wherein DRUG is any steroid agonist or antagonist, a mixed agonist-antagonist, or a partial agonist and the substituents are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.